3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Squamous Cell Carcinoma of Head and Neck
16
Oropharyngeal Neoplasms
10
Nasopharyngeal Carcinoma
10
Prostatic Neoplasms
7
Laryngeal Neoplasms
6
Rectal Neoplasms
5
Mouth Neoplasms
5
Hypopharyngeal Neoplasms
5
Head and Neck Neoplasms
5
Carcinoma
5
Carcinoma, Non-Small-Cell Lung
4
Esophageal Neoplasms
3
Carcinoma, Squamous Cell
3
Breast Neoplasms
3
Uterine Cervical Neoplasms
2
Urinary Bladder Neoplasms
2
Salivary Gland Neoplasms
2
Precursor Cell Lymphoblastic Leukemia-Lymphoma
2
Nasopharyngeal Neoplasms
2
Mesothelioma
2
Epstein-Barr Virus Infections
2
Carcinoma, Intraductal, Noninfiltrating
2
Astrocytoma
2
Anus Neoplasms
2
Vaginal Neoplasms
1
Urothelial Carcinoma of the Bladder
1
Tongue Neoplasms
1
Thyroid Carcinoma, Anaplastic
1
Stomatitis
1
Stomach Neoplasms
1
Interventions
Doxorubicin
14
pembrolizumab
11
Specimen Handling
11
Magnetic Resonance Spectroscopy
10
Biopsy
9
Cyclophosphamide
8
X-Rays
7
Radiotherapy
7
Nivolumab
7
Ifosfamide
7
Phantoms, Imaging
6
Gemcitabine
6
liposomal doxorubicin
5
Temozolomide
5
Radiation
5
tazemetostat
4
palbociclib
4
Trabectedin
4
Nuclear Medicine Department, Hospital
4
Irinotecan
4
Ipilimumab
4
pazopanib
3
larotrectinib
3
fludarabine
3
cabozantinib
3
atezolizumab
3
Surveys and Questionnaires
3
Radiation Dose Hypofractionation
3
Proton Therapy
3
Carboplatin
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Sarcoma
×
Radiotherapy, Intensity-Modulated
×
90 days
×
Clear all
No trials found.